In the Vanguard of Vaccine Research

Could an HIV vaccine be developed for both prevention and cure? An interview with Dr. Dan Barouch

• Gene-Editing Technology: A Game Changer for HIV Cure Research?
• Dock and Block: Scientists Develop Technique that Makes Cells Resistant to HIV
• A Marker of Latently Infected Cells?

FY2017 U.S. Global AIDS Budget: The Human Impact

Proposed cuts to PEPFAR would lead to tens of thousands of preventable AIDS deaths and new HIV infections.

• How Cures Can Fail
• Recommendations for Health Plans and Health Care Purchasers to Support Efforts to Curb the HIV Epidemic in the U.S.

amfAR-Funded HIV Scholars Program Featured in AIDS and Behavior Supplement

amfAR has partnered with the University of Pittsburgh to produce a supplement to the journal AIDS and Behavior devoted to the HIV Scholars Program at the University’s Center for LGBT Health Research.

• UNAIDS Reports Record Number on Antiretroviral Therapy - Warns Young Women Still at High Risk
• Cervical Cancer in Asia: A Deadly but Preventable Epidemic

Clinging to the Positive

Artist Mykki Blanco discusses living with HIV on National Youth HIV/AIDS Awareness Day.

Straight with HIV: An Interview with Joshua Middleton

In observance of National Youth HIV & AIDS Awareness Day on April 10, we spoke to Middleton about coping in the aftermath of diagnosis, combating HIV stereotypes, and raising awareness among youth.

The Time Is Now!

A collection of classic hits from the 1980s featuring Sugar for Sugar (with Scarlett Johansson), Aloe Blacc, Theophilus London, and many more was created specifically to benefit amfAR.

Countdown to a Cure Timepiece

amfAR's Milestone Partner, Harry Winston, Inc., is launching a limited-edition Countdown to a Cure timepiece to benefit the Foundation's efforts to develop a cure for HIV.